Formulation Trends Shaping Innovation and New Product Development in Nutraceuticals
Formulation Trends Shaping Innovation and New Product Development in Nutraceuticals
Formulation trends across the nutraceutical industry are converging around ingredient innovation, clinical validation, and smarter delivery formats. Ashwagandha continues its rise, driven by standardization and expanding use cases beyond stress and sleep into male health and broader wellness routines, while creatine evolves from a sports nutrition staple into applications spanning brain energy metabolism, healthy aging, and muscle preservation for GLP-1 users. Protein demand remains strong across categories, and cognitive health formulations increasingly combine ingredients like magnesium, ginseng, and adaptogenic botanicals to deliver both acute and long-term benefits. Life-stage-specific clinical research emerges as a critical gap in women's health, and industry experts weigh in on where active nutrition, healthy aging, and women's health formulation are headed next, along with untapped white space in probiotics, postpartum and infant nutrition, and stable liquid delivery formats. Together, these insights offer a data-driven look at where consumer demand and product innovation are converging in 2026.
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
The company says it will center on positive aging, with a focus on lutein research beyond vision, the Gutopia platform, and Slendesta for the GLP-1 market.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
NNB Nutrition says the finished product is the first to carry the certification using its creatine ingredient, which also holds Informed Choice certification and has undergone third-party impurity testing.